ATAI Life Sciences
Anne Johnson joined atai Life Sciences in 2021 as Lead, Global Controller.
Previously, Anne was a Controller at Aruvant, an International Biotechnology Company, focusing on gene therapies for rare diseases. Prior to this, she has held a number of senior leadership roles within the CFO office, include Corporate Controller at Chimerix, Inc and VP Finance at Xanodyne Pharmaceuticals.
She holds a B.Sc in Accounting from the University of North Carolina at Wilmington and is an AICPA qualified accountant.
This person is not in any teams
This person is not in any offices
ATAI Life Sciences
The biotech platform to heal mental health disorders leveraging cutting-edge scientific research and technology.